Pharmacological interventions

TopicPharmacological interventions
Review question(s)For people who self-harm, do pharmacological interventions (compared with no treatment or other interventions) improve outcomes? What are the associated adverse effects?
Sub-question(s)3.2 For people who self-harm, what are the key principles underlying safer prescribing?
Chapter8 – Pharmacological interventions
Sub-section
Topic group8 – Suzanne Kearney, Alison Wood, Paul Gill
Sub-section leadN/A
ObjectivesTo review the effectiveness of interventions for the management of repetition of self-harm behaviour
Criteria for considering studies for the review
  • Intervention
Chapter 8 – Antidepressants, antipsychotics, lithium, anticonvulsants (for example, valproate, carbamazepine, lamotrigine), benzodiazepines, analgesics
  • Comparator
Treatment as usual or placebo
  • Types of participants
Participants (aged 8 years old or above) admitted to hospital for treatment of index episode of self-harm). Self-endorsed self-harming behaviour are also included.
  • Critical outcomes
Repetition (fatal outcome: completed suicide; non-fatal repetition)
  • Important, but not critical outcomes
Depression, hopelessness, suicide ideation scores
  • Other outcomes
N/A
  • Study design
RCTs
  • Include unpublished data?
No
  • Restriction by date?
No
  • Dosage
N/A
  • Minimum sample size
Ten in each treatment arm
  • Study setting
Inpatient and outpatient (as long as participants had history of previous self-harm)
Search strategyDatabases: CINAHL, EMBASE, MEDLINE, HMIC, PsycBOOKS, PsycEXTRA, PsycINFO

New search:
Searching other resourcesExperts in the field were contacted to identify if any key studies were missed.
Existing reviews
  • Updated
Hawton and colleagues' (2011) updated Cochrane review for self-harm interventions
  • Not updated
N/A
General search filter usedSee search strategy in Appendix 9
Question specific search filterSee search strategy in Appendix 9
Amendments to filter/search strategySee search strategy in Appendix 9
The review strategyData from the Cochrane review update will be used for meta-analysis. Studies will be checked for the inclusion criteria.
Additional assessments
  1. Exclude non-randomised studies
  2. Exclude studies that were designed for people with borderline personality disorder (refer to the NICE guideline).

From: Appendix 8, Review protocols

Cover of Self-Harm: Longer-Term Management
Self-Harm: Longer-Term Management.
NICE Clinical Guidelines, No. 133.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society; 2012.
Copyright © 2012, The British Psychological Society & The Royal College of Psychiatrists.

All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.